Clarify Health Solutions

Clarify Health Solutions is an operating company, not an investment fund. Strategic and financial decisions are led by co-founder and CEO Jean Drouin, with the board including representatives from major investors such as KKR, Insight Partners, and SoftBank Vision Fund 2 following their respective funding rounds. The co-founders maintain executive control over product and commercial strategy.

Clarify sells primarily to large U.S. health systems and national health plans engaged in value-based contracting. Its platform is used for clinical variation reduction, network optimization, and managing downside risk in Medicare Advantage and commercial accountable care arrangements. The firm's pricing model is subscription-based, tied to the software platform and underlying data access.

Clarify ingests de-identified claims data, electronic health record feeds, and social determinants information through partnerships with health plans, clearinghouses, and provider organizations. The firm does not collect data directly from patients. Its data ingestion and linking capability — capable of resolving a single patient's journey across multiple disconnected care sites — is the core technical moat. Specific data partner contracts are not publicly disclosed.